DMCC Speciality Chemicals Limited — Q4 FY25 earnings call

Call held 8 May 2025

Management summary

DMCC Speciality reported a strong full year FY25 performance with a top line of INR 430 crores and a 13.5% EBITDA margin, despite Q4 margins being impacted by sulfur price volatility. The company is actively diversifying its export markets away from a struggling Europe and has significant growth potential in its Specialty Chemicals segment. However, the imminent commissioning of a new copper smelter poses a risk to the sulfuric acid market.

Highlights

  • Full year FY25 top line reached INR 430 crores, demonstrating overall growth.

  • EBITDA margins for FY25 stood at a healthy 13.5%.

  • Specialty Chemicals business has significant headroom, with capacity to double current sales of INR 210 crores.

  • Long-term borrowings are now below INR 60 crores, indicating improved financial health.

  • Actively diversifying export markets into Latin America and China to mitigate European slowdown.

Concerns

  • Q4 FY25 EBITDA margins were compressed due to an 'unusual jump' in sulfur prices.

  • Significant loss of exports to Europe due to increased costs and reduced production in the region.

  • Upcoming commissioning of a large copper smelter in Kutch is expected to put downward pressure on the sulfuric acid market.

  • Boron segment faces continuous supply chain issues as there is no raw material in India.

Key financials

2 periods

Q4 FY25

  • Top Line
    ₹125 Cr
  • PAT
    ₹6.47 Cr

FY25

  • Top Line
    ₹430 Cr
  • PAT
    ₹21.5 Cr
  • EBITDA Margin
    13.5%

What they filed

Q1 FY27: revenue up 99.2%, net profit up 150.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue103 118 125 127 126 +22%151 +28%178 +42%253 +99%
EBITDA15 18 15 17 14 −7%15 −17%18 +20%34 +100%
Net profit6 8 6 8 6 +0%6 −25%8 +33%20 +150%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Boron Business
    ₹100 Cr Sales (Past Year)70% Commodity Share30% Higher-Margin Share
  • Specialty Chemicals
    ₹51 Cr Revenue (Q4 FY25)₹210 Cr Annual Revenue (Current Capacity)50% Capacity Utilization50% Full Year Mix (vs Bulk)

Capital allocation

high confidence
  • Capex ₹10 Cr
    • Incremental investment/debottlenecking for mature products ₹10 Cr
    • Annual maintenance for sulfuric acid plants ₹1.5 Cr
    So we are not envisaging any major CAPEX at this time. So yes, you are right. What I said was that no major CAPEX, doesn't mean we are not going to do anything at all. We have a plan of about INR 10 crores to INR 15 crores, but nothing major compared to what we have done, the major expansion at Dahej, which happened over the last few years.
  • Debt Net ₹60 Cr
    We are repaying debt, and our long-term borrowings are now below INR 60 crores. Working capital position is quite comfortable.
  • Liquidity Liquidity disclosed Working capital position is quite comfortable.
    Working capital position is quite comfortable.

Guidance & targets

Capacity

  • Specialty Chemicals Sales Potential Capacity · Ongoing · High confidence INR 420 crores
    in terms of reactor capacity, etc, we are available sufficient to double our current sales of Specialty Chemicals.

    — Bimal Goculdas

Product Development

  • New Products Commercialization Product Development · Next year (FY26) · Medium confidence New products taken up for commercialization
    And in this current year, we will develop some new products, which we'll take up in the next year for commercialization.

    — Bimal Goculdas

Growth

  • Chemical Industry Growth Rate Growth · General · Medium confidence Faster than GDP growth
    So again, typically, the chemical industry grows faster than the GDP growth.

    — Bimal Goculdas

Profitability

  • EBITDA Margin Expansion Profitability · As specialty business expands · Medium confidence Expansion
    But I've always maintained that the specialties are a higher margin. And as we expand our specialty business, we'll see an expansion in the EBITDA margin.

    — Bimal Goculdas

Taxation

  • Transition to New Tax Regime Taxation · Next year or the year after · High confidence New tax regime (25-26%)

    From Old tax regime today

    So both plants are in the same company, and we are currently under the old tax regime, but we expect by next year, we'll go to the new tax regime next year or the year after.

    — Bimal Goculdas

What to watch in Q1 FY26

Specialty Chemicals Margin Recovery

Next quarter (Q1 FY26)
Current Compressed due to sulfur price in Q4 FY25
Target Return to normal profitability

Why it matters

Direct impact on profitability; management expects pass-through of sulfur price increases.

What happened in the previous quarter is an unusual jump in the sulfur price, which will get reflected in the contract pricing in Q1 of this financial year. So we will be able to pass it on.

Risks & concerns

  • European Market Conditions

    high

    Increased costs and reduced production in Europe led to lost export sales for DMCC.

    Management acknowledged

  • Copper Smelter Commissioning in Kutch

    medium

    Expected to put downward pressure on the sulfuric acid market due to byproduct production.

    Management acknowledged

  • Sulfur Price Volatility

    medium

    Unusual jump in sulfur prices impacted Q4 FY25 margins, though pass-through is expected in Q1 FY26.

    Management acknowledged

  • Boron Raw Material Supply Chain Issues

    medium

    No raw material in India leads to continuous supply chain challenges for the boron segment.

    Management acknowledged

Q&A highlights

7 direct
Impact of new copper smelter on sulfuric acid market Direct
The correlation is that copper smelters have a byproduct of sulfuric acid, and they can have this without burning sulfur. So when sulfur prices are low, it doesn't matter that much. But when sulfur prices are high, all the sulfur-based sulfuric acid plants are at a disadvantage compared to the smelter-based sulfuric acid plants.

Highlights a significant upcoming competitive threat and its mechanism of impact on DMCC's core business.

Asked by Yash Pareek

Timing and scale of future CAPEX Direct
We have a plan of about INR 10 crores to INR 15 crores, but nothing major compared to what we have done, the major expansion at Dahej, which happened over the last few years. We have nothing like that planned and what we will do is as we increase our utilization of the multipurpose plants, when we find that there's any particular product which is mature, we'll take it out of there and we'll put it into a dedicated plant, in which case, we'll come back to the Board and to the shareholders for the necessary CAPEX.

Clarifies the company's conservative capital allocation strategy and future growth path through product maturity rather than large-scale immediate expansion.

Asked by Yash Pareek

R&D initiatives and new product pipeline Partial
Yes. So we are working on several niche products. And it's competitively not to our advantage to specify which products are going to be our focus. But they are within the sulfur and boron chemicals specialty space.

Indicates ongoing R&D efforts in core areas but a lack of specific disclosure due to competitive reasons, which can be a concern for investors seeking transparency on future growth drivers.

Asked by Yash Pareek

Quantifying impact of plant shutdowns in Q4 FY25 and Q1 FY26 Direct
At Dahej, we had a smaller shutdown because it was spread across a little bit a few days in the previous quarter, which is Q3 and about 10 days in Q4. So you could say we lost 10 to 15 days production out of possible 90 days production during that particular quarter. And we have a shutdown in Roha in Q1 of '25-'26, and that will be a slightly longer shutdown. That is about 20 days to 25 days total shutdown time.

Provides specific operational details and quantifies the direct impact of maintenance shutdowns on production and sales for the current and upcoming quarters.

Asked by Yashvi

EBITDA margin compression due to sulfur prices and recovery outlook Direct
What happened in the previous quarter is an unusual jump in the sulfur price, which will get reflected in the contract pricing in Q1 of this financial year. So we will be able to pass it on.

Addresses the reason for Q4 margin pressure and provides a clear expectation for margin recovery in the next quarter due to price pass-through mechanisms.

Asked by Yashvi

Strategy for European market slowdown and new market penetration Direct
And we are looking at and we have been active in developing new markets. So we are making some headway in Latin American countries, where we have seen decent growth. And we are also selling some products into China, which we were not doing earlier. And while both of these have not yet made up for the loss of the European business, we believe that over a period of time, it will get substituted.

Outlines the company's strategic response to a major export market challenge and its efforts to diversify geographically, while acknowledging the current shortfall.

Asked by Yashvi

Specialty Chemicals capacity utilization and revenue potential Direct
So certainly, it can grow. I won't project a particular number, but we have enough headroom and we have enough space available within our existing plants. And in terms of reactor capacity, etc, we are available sufficient to double our current sales of Specialty Chemicals.

Quantifies the significant organic growth potential within the higher-margin Specialty Chemicals segment without requiring major immediate CAPEX.

Asked by Ankit Gupta

Boron segment contribution to revenue and margin profile Direct
I would have to check, but roughly about INR 100 crores, INR 90 crores to INR 100 crores, something like that. ... Not entirely. About 70% or so is the commodities. ... But suffice to say that the Specialty Chemicals business in general has a higher margin than the bulk chemicals.

Provides insight into the scale and product mix of the boron segment, clarifying its contribution to overall revenue and its margin characteristics relative to other segments.

Asked by Ankit Gupta

2 min read 6 chapters

Detailed narrative

Q4 FY25 and Full Year FY25 Financial Performance

DMCC Speciality Chemicals reported a Q4 FY25 top line of INR 125 crores and a PAT of INR 6.47 crores. For the full financial year 2025, the company achieved a top line of INR 430 crores and a PAT of INR 21.5 crores. The full year EBITDA margin stood at approximately 13.5%. Management highlighted that the previous year's Q4 included an INR 8 crore pre-tax profit from investment sales, which should be considered when comparing year-on-year performance.

European Market Challenges and Diversification Strategy

The company faced significant headwinds in European markets, experiencing a loss of export sales due to increased energy costs and reduced production by European chemical companies. In response, DMCC is actively exploring and developing new markets, making headway in Latin American countries and initiating sales into China. While these new markets have not yet fully compensated for the lost European business, management believes they will eventually substitute the demand, anticipating that European industry will eventually take steps to revive itself.

Impact of Upcoming Copper Smelter on Sulfuric Acid Market

A key concern raised by management is the imminent commissioning of a large copper smelter in Kutch, expected within the next 3 to 6 months. This smelter will produce sulfuric acid as a byproduct, which is anticipated to create downward pressure on the sulfuric acid market, particularly in Northern Gujarat. This development could put sulfur-based sulfuric acid plants, like DMCC's, at a disadvantage when sulfur prices are high, as smelter-based production does not incur sulfur burning costs.

Specialty Chemicals Growth Potential and Capacity Utilization

DMCC's Specialty Chemicals business is currently operating at 50-60% capacity utilization, generating an annual revenue of approximately INR 210 crores. Management stated that the company possesses sufficient reactor capacity to double its current sales in this segment, implying a potential annual revenue of around INR 420 crores. Future growth will focus on increasing utilization and, for mature products, transitioning them to dedicated plants with modest CAPEX of INR 10-15 crores.

Raw Material Price Volatility and Margin Management

The company's EBITDA margins in Q4 FY25 were impacted by an 'unusual jump' in sulfur prices. However, DMCC expects to pass on these raw material cost increases through contract pricing adjustments, with the effect anticipated to be reflected in Q1 FY26. The boron segment, which contributed about INR 100 crores in sales in the past year, comprises roughly 70% commodities and 30% higher-margin products, with specialty chemicals generally yielding better margins than bulk chemicals.

Capital Expenditure and Debt Management

DMCC is not planning any major capital expenditure at this time, with only a modest plan of INR 10-15 crores for incremental investments or debottlenecking. The company's long-term borrowings have been reduced to below INR 60 crores, and its working capital position is described as comfortable. Annual maintenance CAPEX for sulfuric acid plants typically ranges from INR 1.5-2 crores every one to two years.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls